USPTO 2015–2025 USPTO PatentsView Foreign Corporation

4D Pharma Research Limited

USPTO PatentsView assignee record - 49 granted patents across 11 technology areas, active 2016–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

17.3

Avg claims per patent

+33%

5-year filing velocity

The verdict

4D holds 49 US patents across 11 technology areas, rank #6,731 of 50,000 tracked assignees.

#6,731
of 50,000 US assignees by volume: Top 40%
by Innovation Score (38.8/100): 17.3
avg claims per patent: +33%
filing velocity, last 5 yrs

Portfolio overview

4D Pharma Research Limited has been granted 49 US utility patents between 2016 and 2023, placing 4D Pharma Research Limited at rank #6,731 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.3 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, 4D Pharma Research Limited is one of the more focused assignees in the PatentsView dataset. By volume, 4D sits between Wichita State University (50 patents, rank #6,727) and Andritz OY (49 patents, rank #6,735) - the closest US assignees by grant volume. The composite Innovation Score of 38.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 28 grants, compared with 21 in the 2015–2019 window, a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. 4D Pharma Research Limited's 17.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 4D Pharma Research Limited against peers pursuing similar technology classes.

Wichita State Uni…

50
inmusic Brands

50
medmix Switzerland

50
varmour Networks

50
A L M T

49
AGFA Graphics

49
Agjunction

49
Andritz OY

49
4D Pharma Research ◀

49

What this shows 4D holds 49 patents at rank #6,731, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 4D

By rank, the assignees closest to #6,731 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in 4D's primary technology class.

4D's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

4D Pharma Research Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.0%
2017	3	6.1%
2018	5	10.2%
2019	12	24.5%
2020	7	14.3%
2021	8	16.3%
2022	12	24.5%
2023	1	2.0%

Which technologies does 4D Pharma Research Limited patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 47

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 47

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 33

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 31

C12R - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS 27

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 26

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 24

A23C - DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF 13

A23K - FODDER 7

C07K - PEPTIDES 5

A23P - SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS 3

Top 11 of 11 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#6,731

Across all tracked assignees

Innovation Score

38.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does 4D Pharma Research Limited hold?

4D Pharma Research Limited holds 49 US granted patents filed between 2016 and 2023, spanning 11 technology areas.

What is 4D Pharma Research Limited's Innovation Score?

4D Pharma Research Limited has an Innovation Score of 38.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does 4D Pharma Research Limited focus on?

4D Pharma Research Limited's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 47 patents. The company has filed patents in 11 CPC subclasses total.

Is 4D Pharma Research Limited's patent filing rate increasing or decreasing?

4D Pharma Research Limited's recent filing velocity is +33% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for 4D Pharma Research Limited's patents?

4D Pharma Research Limited's patents average 17.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the 4D Pharma Research Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

4D's 49 grants land it in the top 40% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - 4D ranks #6,731 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.